Thomas Edward Hamilton's Insider Trades & SAST Disclosures
Thomas Edward Hamilton's most recent trade in Annaly Capital Management Inc was a trade of 8,583 Deferred Stock Units done . Disclosure was reported to the exchange on May 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas Edward Hamilton.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annaly Capital Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 8,583 | 36,282 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 16 Feb 2024 | 57,208 | 564,798 | - | 8.7 | 499,998 | Common Stock |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Annaly Capital Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 8,167 | 27,698 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 16 Sep 2022 | 317,460 | 507,590 | - | 3.2 | 999,999 | Common Stock |
| Annaly Capital Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 24,372 | 78,124 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 8.75 per share. | 30 Jun 2021 | 56,710 | 190,130 | - | 8.8 | 496,213 | Common Stock |
| Annaly Capital Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 15,609 | 53,752 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 8,300 | 8,300 | - | - | Stock Option (right to buy) | |
| Annaly Capital Management Inc | Thomas Edward Hamilton | Director | Sale of securities on an exchange or to another person at price $ 9.18 per share. | 03 May 2021 | 80,000 | 0 (0%) | 0% | 9.2 | 734,432 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges